Company profile
SMITH & NEPHEW PLC
NYSE:SNNIndustrial Specialties
Drug pipeline (25)
| Asset | Stage | Revenue | Trials | Status |
|---|---|---|---|---|
| AMINOPHYLLINE | approved | — | 0 | — |
| CLINDAMYCIN PHOSPHATE | approved | — | 0 | — |
| CYANOCOBALAMIN | approved | — | 1 | approved |
| DOPAMINE HYDROCHLORIDE | approved | — | 0 | — |
| DROPERIDOL | approved | — | 0 | — |
Revenue is the latest quarter the company reported for that product, from SEC filings; a fourth quarter is the year less nine months when no filing states one. Trial counts are of the product's ingredients, deduplicated by trial, so products sharing an ingredient share trials.
Clinical trials (3)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT02718625 | phase4 | terminated | 2016-08-01 | 2017-03-09 | Smith & Nephew, Inc. | Study of SANTYL® vs Hydrogel (SoloSite®) for Pressure Ulcers |
| NCT02716519 | phase4 | withdrawn | 2016-08-01 | 2018-12-01 | Smith & Nephew, Inc. | Use of Santyl Within an Accountable Care Organization |
| NCT02581488 | phase4 | completed | 2015-10-01 | 2017-01-12 | Smith & Nephew, Inc. | Use of Santyl in Diabetic Foot Ulcers |
FDA applications (76)
| Application | Approved | Type | Applicant | Products | ||||
|---|---|---|---|---|---|---|---|---|
| ANDA 071750 | 1988-09-06 | ANDA | SMITH AND NEPHEW SOLOPAK DIV SMITH AND NEPHEW | |||||
Loading… | ||||||||
| ANDA 071754 | 1988-09-06 | ANDA | SOLOPAK LABORATORIES INC | |||||
Loading… | ||||||||
| ANDA 071755 | 1988-09-06 | ANDA | SOLOPAK LABORATORIES INC | |||||
Loading… | ||||||||
| ANDA 062852 | 1988-03-17 | ANDA | SOLOPAK LABORATORIES INC | |||||
Loading… | ||||||||
| ANDA 062819 | 1988-03-15 | ANDA | SOLOPAK LABORATORIES INC | |||||
Loading… | ||||||||